Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 28, 2026International Journal of HyperthermiaOpen Access

Eliminating cancer stem cells can inhibit progression of residual hepatocellular carcinoma after radiofrequency ablation

View Full Paper
Ask AI
Bookmark
Share

Authors

BWBing WangYSYu-Han ShenSWSong Wang

Discussion

Loading...

Member takes

Overview

Experimental study shows ERK inhibitor combined with Sal inhibits tumor progression, indicating potential treatment strategies.

Key Points

  • The aim is to explore how eliminating cancer stem cells can slow down the growth of leftover liver cancer after treatment.
  • Utilized radiofrequency ablation (RFA) as the primary treatment method.
  • Assessed the effects of an ERK inhibitor combined with Sal on cancer cell behavior.
  • Measured changes in cell proliferation, migration, and stemness in residual tumors.
  • Combining the ERK inhibitor with Sal significantly reduced cell proliferation.
  • The treatment decreased migration of cancer cells in residual tumors.
  • Reduction in stemness markers suggests inhibited tumor progression.

Cite This Study

Wang et al. (2026) studied this question.

synapsesocial.com/papers/69c7724e8bbfbc51511e2b44https://doi.org/10.1080/02656736.2026.2643510
View Full Paper
Ask AI
Bookmark
Share